What is the ExCel Study?
Breast cancer is the most common form of cancer in women. In 2004, more than 1.2 million people worldwide were diagnosed with this disease. Breast cancer can occur in adults at any age.
Recent research in breast cancer has helped thousands of women beat their disease and researchers are dedicated to finding even better treatment options. Recent efforts are also now focusing on new medications that may reduce the occurrence of breast cancer in women who are at an increased risk for developing this disease.
The ExCel research study is a breast cancer prevention clinical trial. It is an important international clinical trial designed to determine whether a special type of medication can prevent breast cancer in healthy postmenopausal women who are at an increased risk for developing breast cancer.
More than 4,500 women will take part in the ExCel research study.